NCT06995898 2026-03-18The Vanguard Study: Testing a New Way to Screen for CancerNational Cancer Institute (NCI)Phase NA Recruiting24,000 enrolled
NCT06626256 2025-12-24STIL101 for Injection for the Treatment of Locally Advanced, Metastatic or Unresectable Pancreatic Cancer, Colorectal Cancer, Renal Cell Cancer, Cervical Cancer and MelanomaCity of Hope Medical CenterPhase 1 Withdrawn
NCT04067960 2024-08-14Pharmacogenomics Testing in the Optimal Use of Supportive Care Medications in Stage III-IV CancerMayo ClinicPhase EARLY_PHASE1 Completed197 enrolled
NCT03878524 2024-03-04Serial Measurements of Molecular and Architectural Responses to Therapy (SMMART) PRIME TrialOHSU Knight Cancer InstitutePhase 1 Terminated2 enrolled
NCT05238831 2024-01-23SMMART Adaptive Clinical Treatment (ACT) TrialOHSU Knight Cancer InstitutePhase EARLY_PHASE1 Withdrawn
NCT05733000 2023-03-10CPI-613 (Devimistat) in Combination With Hydroxychloroquine and 5-fluorouracil or Gemcitabine in Treating Patients With Advanced Chemorefractory Solid TumorsNorthwestern UniversityPhase 2 Recruiting94 enrolled